Evidence map›Paper›PMID 41606654›Full record

ArticleGenome biology2026

Resolving clonal evolution and selection of extrachromosomal DNA at single-cell resolution.

Josephine Deleuran Hendriksen, Alessio Locallo, Balthasar Clemens Schlotmann, Francisco Germán Rodríguez González, Jane Skjøth-Rasmussen, Christina Westmose Yde, Dorte Schou Nørøxe, Hans Skovgaard Poulsen, Ulrik Lassen, Joachim Weischenfeldt

Abstract read
In one paragraph

Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Evolution of oncogene amplification across 86,000 cancer cell genomes.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Josephine Deleuran HendriksenThe Finsen Laboratory, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Alessio LocalloThe Finsen Laboratory, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Balthasar Clemens SchlotmannThe Finsen Laboratory, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Francisco Germán Rodríguez GonzálezThe Finsen Laboratory, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Jane Skjøth-RasmussenThe DCCC Brain Tumor Center, Danish Comprehensive Cancer Center, Copenhagen, Denmark.
Christina Westmose YdeDepartment of Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Dorte Schou NørøxeThe DCCC Brain Tumor Center, Danish Comprehensive Cancer Center, Copenhagen, Denmark.
Hans Skovgaard PoulsenThe DCCC Brain Tumor Center, Danish Comprehensive Cancer Center, Copenhagen, Denmark.
Ulrik LassenThe DCCC Brain Tumor Center, Danish Comprehensive Cancer Center, Copenhagen, Denmark.
Joachim WeischenfeldtThe Finsen Laboratory, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. joachim.weischenfeldt@bric.ku.dk.

Funding

Danmarks Frie Forskningsfond 3101-00177Kræftens Bekæmpelse R295-A16770Novo Nordisk Fonden NNF200C0060141
6 · The paper itself

Abstract

backgroundGenomic alterations are a hallmark of cancer, and extrachromosomal DNA (ecDNA) has emerged as a key source of oncogene selection, tumor growth, and drug resistance. The intratumor heterogeneity and clonal selection of ecDNA is, however, poorly understood.

resultsIn this study, we pursue a computational approach that leverages allelic imbalance and outlier expression from standard single-cell RNA sequencing (scRNA-seq) to deconvolve the tumor heterogeneity of ecDNA at the single-cell level (ecSingle). Using this approach, we identify oncogene-carrying ecDNAs in tumor samples at the single-cell level, which we validate using genome sequencing. Moreover, we show the superiority of using single-molecule long-read sequencing in resolving ecDNA. ecDNAs displayed extensive intratumor heterogeneity, including subclonal oncogene-carrying ecDNA in primary tumor cells that segregate with distinct transcriptional cell states. Importantly, we show that a rare ecDNA+ clone in the primary tumor can expand to form dominant clones in relapse tumors.

conclusionsOur study introduces a novel approach to studying ecDNA at the single-cell level, enabling both clonal evolution and transcription cell state analysis. We apply this approach to cancer samples to gain deeper insights into the role of ecDNA in intratumor heterogeneity and cellular plasticity.

Indexed as

Clonal EvolutionExtrachromosomal DNANeoplasmsSingle-Cell AnalysisHumansOncogenesSingle-Cell Gene Expression AnalysisExtrachromosomal DNACancerClonal evolutionExtrachromosomal DNALong-read sequencingOncogene amplificationSingle cell

Identifiers

PMID41606654
PMCPMC12853921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.